Adaptimmune Therapeutics PLC: Nasdaq/NYSE listing notice — Adaptimmune receives Nasdaq delisting notice for MVLS below $35M; 180-day cure period

Adaptimmune Therapeutics PLC

Nasdaq notified Adaptimmune on Sept 11, 2025 that MVLS was below $35M minimum for 32 consecutive business days.
Company also fails alternative continued listing standards: equity below $2.5M or net income below $500K.
Has 180 calendar days (until March 10, 2026) to regain MVLS compliance for at least 10 consecutive business days.
No immediate effect on ADAP ADS trading; failure to comply may result in delisting with appeal option.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Adaptimmune Therapeutics PLC received a nasdaq deficiency notice notice regarding other (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5550(b)(2)

Exact text from the filing

September 11, 2025, Adaptimmune Therapeutics plc (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 32 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (“MVLS”) was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “MVLS Listing Rule”). Additionally, as of the date of the Notice, the Company did not mee

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Adaptimmune Therapeutics PLC received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

September 11, 2025, Adaptimmune Therapeutics plc (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 32 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (“MVLS”) was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “MVLS Listing Rule”). Additionally, as of the date of the Notice, the Company did not mee

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-25-089558

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.